CLINICAL_TRIALS
trial_result
· 2009-12-07
Clinical Trial Update: OculusGen™ Collagen Matrix Implant for Phaco-Trabeculectomy in Primary Glaucoma: a Case-Control Study [Phase 3]
Summary
The Phase 3 case-control trial evaluating the OculusGen Collagen Matrix Implant for phaco-trabeculectomy in primary glaucoma has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Singapore National Eye Centre | Conditions: Glaucoma | Phase 3 | Status: COMPLETED